ISRCTN23196537已完成不适用
A randomised placebo-controlled trial of epirubicin and quinidine in patients with advanced breast cancer
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically proven metastatic or locally advanced disease
- •2. Measurable or evaluable disease
- •3. World Health Organisation (WHO) Performance status at least 2
- •4. Haemoglobin =10 g%
- •5. White Blood Count (WBC) >4.0 x10^9/l
- •6. Platelets =100 x 10^9/l
- •7. Bilirubin within normal range
- •8. Not currently receiving hormone treatment
- •9. No prior chemotherapy for advanced disease
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
A phase II/III randomised trial comparing Epirubicin, Cisplatin and Protracted Venous Infusion (PVI) 5-Fluorouracil (5-FU) (ECF), Epirubicin, Oxaliplatin and PVI 5-FU (EOF), Epirubicin, Cisplatin and Capecitabine (ECX) and Epirubicin, Oxaliplatin and Capecitabine (EOX) in Patients with Advanced Oesophago-Gastric CancerCancerISRCTN51678883The Royal Marsden NHS Foundation Trust (UK)1,000
进行中（未招募）
1 期
A randomised, placebo controlled trial of levobupivacaine or the combination of levobupivacaine and clonidine when administered as a sciatic perineural infusion for the prevention of phantom limb pain and cardiac morbidity after lower limb amputation - Incidence of phantom limb pain after lower limb amputatioPain after amputationMedDRA version: 8.1 Level: LLT Classification code 10004227 Term: Below knee amputationMedDRA version: 9.1 Level: LLT Classification code 10000243 Term: Above knee amputationEUCTR2006-005667-26-GBinewells Hospital300
已完成
不适用
A randomised, placebo controlled trial of levobupivacaine or the combination of levobupivacaine and clonidine when administered as a sciatic perineural infusion for the prevention of phantom limb pain after lower limb amputatioPhantom limb pain in amputation casesNervous System DiseasesNerve root and plexus disordersISRCTN31319378HS Tayside (UK)180
进行中（未招募）
不适用
A randomised, placebo controlled trial of the efficacy of the addition of spironolactone to modern antihypertensive treatment regimes in patients with resistant hypertension.EUCTR2006-004846-17-GBSheffield Teaching Hospitals NHS Foundation Trust
招募中
不适用
Phase II randomized controlled trial of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000011785Takasaki General Medical Center, National Hospital Organization60